Bradmer Pharmaceuticals Inc. Announces Termination of Proposed Reverse Take-Over Transaction With P1 Energy Corp.
15 Julio 2011 - 3:15PM
Marketwired
Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today
that P1 Energy Corp. and Bradmer have mutually agreed to terminate
the letter of intent between the parties relating to a proposed
reverse take-over transaction. In connection with the termination
of the letter of intent, P1 Energy agreed to pay the costs and
expenses incurred by Bradmer in pursuing the transaction. The
proposed transaction was initially announced by Bradmer on February
10, 2011 and trading of the common shares of Bradmer has been
halted since that date. It is anticipated that the common shares of
Bradmer will resume trading on the NEX Board of the TSX Venture
Exchange on July 19, 2011.
The directors and officers of Bradmer intend to seek out new
opportunities considered to be in the best interests of Bradmer and
its shareholders.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS
THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
Contacts: Bradmer Pharmaceuticals Inc. Paul Van Damme
416.987.6113 pvandamme@bradmerpharma.com
Bradmer Pharmaceuticals (TSXV:BMR.H)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Bradmer Pharmaceuticals (TSXV:BMR.H)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Bradmer Pharmaceuticals (TSX Venture Exchange): 0 recent articles
Más de Bradmer Pharmaceuticals Inc. Artículos de Noticias